recurrent adult acute myeloid leukemia
Semantic Scholar uses AI to extract papers important to this topic.
Abstract The CLL-IPI is a risk-weighted prognostic model for previously untreated patients with chronic lymphocytic leukemia (CLL… Expand AbstractThe aim of this study was to investigate the role of microRNA-335 (miR-335) in determining the treatment response and… Expand Objective:To summarize the therapy strategies for relapsed adult acute myeloid leukemia(AML) with MLL gene arrangement after… Expand BACKGROUND
Colorectal cancer (CRC) patients whose tumours have microsatellite instability (MSI) do not benefit from adjuvant 5… Expand A large proportion of adult patients with acute myeloid leukemia (AML) relapse after treatment, and some of them are resistant to… Expand BACKGROUND
Bortezomib is an inhibitor of proteasome and NF-kappaB, with activity in various solid tumors and hematological… Expand Background : High-dose cytarabine (HDAC) and etoposide, two of the most active drugs in relapsed acute myeloid leukemia (AML… Expand Main chemotherapy regimens used to treat adult patients with acute myeloid leukemia (AML) in first or further relapse were… Expand BACKGROUND AND OBJECTIVE
High-dose cytarabine (HDAra-C), mitoxantrone and etoposide are the mainstay of several active regimens… Expand